Cargando…

Effect of continuing the use of renin–angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis

BACKGROUND: The effect of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on mortality was preliminarily explored through the comparison of ACEIs/ARBs with non-ACEIs/ARBs in patients with coronavirus disease 2019 (COVID-19). Reaching a conclusion on whether prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qi, Fu, Wei, Zhu, Chang-ju, Ding, Zi-heng, Dong, Bin-bin, Sun, Bao-qing, Chen, Rong-chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872739/ https://www.ncbi.nlm.nih.gov/pubmed/36694122 http://dx.doi.org/10.1186/s12879-023-07994-7

Ejemplares similares

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
por: Pranata, Raymond, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019
por: Bae, Seongman, et al.
Publicado: (2020)

Renin–angiotensin system inhibitor use and colorectal cancer risk and mortality: A dose–response meta analysis
por: Chen, Xia, et al.
Publicado: (2020)

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis
por: Ling, Qiong, et al.
Publicado: (2018)

Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19)
por: Zhang, Qingguang, et al.
Publicado: (2022)

Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
por: Nawangsih, Eka Noneng, et al.
Publicado: (2021)

Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression
por: Pardamean, Engelberta, et al.
Publicado: (2022)

Efficacy and Safety of Renin-Angiotensin Aldosterone System Inhibitor in Patients with IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials
por: ZHAO, Yu, et al.
Publicado: (2019)

Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system
por: Jin, Ze-Ning, et al.
Publicado: (2016)

Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury
por: Ventura, Davide, et al.
Publicado: (2021)

Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
por: Zanza, Christian, et al.
Publicado: (2021)

Renin–angiotensin system in human coronavirus pathogenesis
por: Wevers, Brigitte A, et al.
Publicado: (2010)

Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia
por: Lee, Hae-Young, et al.
Publicado: (2021)

Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression
por: Siahaan, Yusak Mangara Tua, et al.
Publicado: (2022)

Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
por: Makani, Harikrishna, et al.
Publicado: (2013)

The role of genetic polymorphisms of the Renin–Angiotensin System in renal diseases: A meta-analysis
por: Braliou, Georgia G., et al.
Publicado: (2014)

Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis
por: Nehme, Ali, et al.
Publicado: (2015)

Meta-analysis of effect of renin–angiotensin–aldosterone system blockers on contrast-induced nephropathy
por: Wang, Weidong, et al.
Publicado: (2020)

Renin–angiotensin system gene polymorphisms and colorectal cancer risk: a meta-analysis
por: Cheng, Zhen, et al.
Publicado: (2019)

Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis
por: Loh, Huai Heng, et al.
Publicado: (2022)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
por: Dai, Xiao-Ce, et al.
Publicado: (2021)

Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression
por: Hariyanto, Timotius I., et al.
Publicado: (2021)

Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression
por: Siahaan, Yusak Mangara Tua, et al.
Publicado: (2021)

Effect of Angiotensin–Neprilysin Versus Renin–Angiotensin System Inhibition on Renal Outcomes: A Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2021)

Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis
por: Ssentongo, Anna E, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
por: Rakhmat, Iis Inayati, et al.
Publicado: (2021)

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19
por: Usman, Muhammad Shariq, et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
por: Hassib, Mohab, et al.
Publicado: (2021)

META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
por: Sattar, Yasar, et al.
Publicado: (2021)

An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes
por: Kurdi, Amanj, et al.
Publicado: (2022)

Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors
por: Lee, Terry, et al.
Publicado: (2021)

Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
por: Hasan, Syed Shahzad, et al.
Publicado: (2020)

Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
por: Zemlin, Annalise E, et al.
Publicado: (2020)

The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis
por: Cheungpasitporn, Wisit, et al.
Publicado: (2016)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

The renin–angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis
por: Zhou, Qi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8b8e6v3fl2mlboqmrrpgf3gvp8